Genomill Health
Finland
unknown
unknown
Stage
About
Genomill Health develops precision molecular diagnostic tests using their patented Geno1® sample preparation technology, which combines molecular biology, robotics, next-generation DNA sequencing, and artificial intelligence to enhance the scalability, cost, accuracy, and turnaround time of liquid biopsies and other diagnostics.
Explore Genomill Health's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.